Euphoria Mega Study
Contents
Euphoria
Euphoria

Related

A
1 to 5 Rating
A
Symptoms
A
Factors
A
Effects
A
User Variables 3
A
Measurements 328

Tags

Euphoria
Euphorium

Treatments Causing Euphoria

User-reported treatments that exhibited the side effect of Euphoria

Treatment Percent of Reports
Maxalt 0%
Rizatriptan (Maxalt) 0%

Below is the degree of change seen after Euphoria is higher than average.

Below is the change in Euphoria seen after the predictor is higher than average.

Outcomes
of
Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change in the listed outcome after is higher than average.
Predictors
of
Below is the change in after the listed predictor is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change from the average seen after the predictor is higher than average.

Euphoria Info

Property Value
Variable Name Euphoria
Aggregation Method MEAN
Analysis Performed At 2020-10-09
Duration of Action 24 hours
Kurtosis 2.8219536277732
Maximum Allowed Value 5 out of 5
Mean 2.6979 out of 5
Median 2.76785 out of 5
Minimum Allowed Value 1 out of 5
Number of Aggregate Predictors 57
Number of Aggregate Outcomes 26
Number of Measurements 328
Number of Measurements (including those generated by tagged, joined, or child variables) 328
Public true
Onset Delay 0 seconds
Standard Deviation 0.33478832709641
Unit 1 to 5 Rating
User Variables 3
UPC 0
Variable Category Symptoms
Variable ID 87237
Variance 0.22416644792003